Keywords :
Case report, Magnesium Sulfate, Myocarditis, Pheochromocytoma
Citation Information :
Misra S, Tripathi M, Malviya D, Yadav SK, Gupta R. Pheochromocytoma-induced Myocarditis: Is Magnesium Sulfate the Choice for Managing the Catastrophe?—A Case Report. World J Endoc Surg 2024; 16 (1):20-23.
Pheochromocytomas are rare neuroendocrine tumors. The catecholamine-secreting tumors make patients prone to life-threatening cardiovascular complications like uncontrolled hypertension, dysrhythmias, cardiac ischemia, and myocardial dysfunction. The goal of preoperative medication is to normalize blood pressure and heart rate, optimize glucose and electrolytes, and assess other end organ functions (cardiomyopathy) for better perioperative outcomes in patients.
About one-fifth to one-third of patients lead to cardiovascular complications, which is associated with high morbidity and mortality. Rarely, these patients present with myocarditis/cardiogenic shock in a preoperative period, which needs urgent medical treatment and management.
We present a case of a 47-year-old female scheduled to undergo adrenalectomy for pheochromocytoma, who presented with myocarditis preoperatively and was well managed with magnesium sulfate.
Roghi A, Pedrotti P, Milazzo A, et al. Adrenergic myocarditis in pheochromocytoma. J Cardiovasc Magn Reson 2011;13(4). DOI: 10.1186/1532-429X-13-4
Magalhães LC, Darze ES, Ximenes A, et al. Acute myocarditis secondary to pheochromocytoma. Arq Bras Cardiol 2004;83(4):346–348. PMID: 15517048.
Imperato-McGinley J, Gautier T, Ehlers K, et al. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med 1987;316(13):793–797. DOI: 10.1056/NEJM198703263161307
Sardesai SH, Mourant AJ, Sivathandon Y, et al. Phaeochromocytoma and catecholamines-induced cardiomyopathy presenting as heart failure. Br Heart J 1990;63(4):234–237. DOI: 10.1136/hrt.63.4.234
Kizer JR, Koniaris LS, Edelman JD, et al. Pheochromocytoma crisis, cardiomyopathy, and hemodynamic collapse. Chest 2000;118(4):1221–1223. DOI: 10.1378/chest.118.4.1221
Curyło A, Jankowski P, Kawecka-Jaszcz K. Pheochromocytoma mimicking acute myocarditis. Kardiol Pol 2004;60(2):145–148. PMID: 15116161.
Varghese RT, John AM, Paul TV. Catecholamine induced cardiomyopathy in pheochromocytoma. Indian J Endocrinol Metab 2013;17(4):733–735. DOI: 10.4103/2230-8210.113771
Jiang X, Zhang W, Fang Q. Pheochromocytoma-related cardiomyopathy presenting as acute myocardial infarction: a case report. Medicine (Baltimore) 2021;100(11):e24984. DOI: 10.1097/MD.0000000000024984
James MF, Cronjé L. Pheochromocytoma crisis: the use of magnesium sulfate. Anesth Analg 2004;99(3):680–686. DOI: 10.1213/01.ANE.0000133136.01381.52
Sanabria C, Vendrell M. Severe cardiomyopathy secondary to pheochromocytoma: Usefulness of magnesium sulfate case report. Colombian J Anesthesiol 2016;44(1):58–62. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/74
Krueger CK, Turner KA, Moreno RA, et al. Magnesium infusion for refractory non-surgical pheochromocytoma crisis. Southwest Resp Crit Care Chronicl 2019;7(30):47–50. DOI: 10.12746/swrccc.v7i30.531
Herroeder S, Schönherr ME, De Hert SG, et al. Magnesium–essentials for anesthesiologists. Anesthesiology 2011;114(4):971–993. DOI: 10.1097/ALN.0b013e318210483d
Vendrell M, Martín N, Tejedor A, et al. Magnesium sulphate and (123)I-MIBG in pheochromocytoma: two useful techniques for a complicated disease. Rev Esp Anestesiol Reanim 2016;63(1):48–53. DOI: 10.1016/j.redar.2015.04.001
